DrugDashboards

Eptifibatide

Eptifibatide · EPTIFIBATIDE 200 mg/100mL · Injection · Intravenous · Eugia US LLC

NDC 55150-0220-99 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 100 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$500.00
Reported to Texas DSHS · 2026 annual filing · Eugia Us Llc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA206127
TE code
AP
Approval date
Dec 8, 2015
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · OngoingMay 22, 2024
    Eugia US LLCFailed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.

Manufacturers of Eptifibatide (Injection)

LabelerStrengthFirst seenLast seen
Slate Run Pharmaceuticals, LLCEPTIFIBATIDE .75 mg/mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CompanyEPTIFIBATIDE 75 mg/100mLJul 15, 2026Sep 2, 2026
Eugia US LLCEPTIFIBATIDE 20 mg/10mLJul 15, 2026Sep 2, 2026
Eugia US LLCEPTIFIBATIDE 200 mg/100mLJul 15, 2026Sep 2, 2026
Eugia US LLCEPTIFIBATIDE 75 mg/100mLJul 15, 2026Sep 2, 2026
Slate Run Pharmaceuticals, LLCEPTIFIBATIDE 2 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Eptifibatide — NDC 55150-0220-99," retrieved September 3, 2026, https://drugdashboards.com/drug/55150022099.

Free to cite with attribution — see how the data is put together.